Standard Biotools (LAB) Retained Earnings (2010 - 2026)

Standard Biotools (LAB) has 17 years of Retained Earnings data on file, last reported at $1.7 billion in Q1 2026.

• On a quarterly basis, Retained Earnings rose 243.7% year-over-year to $1.7 billion in Q1 2026; TTM through Mar 2026 was $1.7 billion, a 243.7% increase from a year earlier, with the FY2025 full-year figure at $1.7 billion, up 141319.84% from the prior year.
• Retained Earnings for Q1 2026 stood at $1.7 billion, up from $1.7 billion in the prior quarter.
• Over the last five years, Retained Earnings for LAB reached as high as $1.7 billion in Q1 2026 and fell as low as -$1.3 billion in Q3 2025.
• Historically, Retained Earnings has averaged $287.8 million across 5 years, with a median of $1.2 million in 2024.
• Across the five-year window, Retained Earnings tumbled 226.92% in 2024 and jumped 141319.84% in 2025, its largest moves.
• Year by year, Retained Earnings stood at -$926.1 million in 2022, then soared by 99.76% to -$2.2 million in 2023, then soared by 155.16% to $1.2 million in 2024, then soared by 141319.84% to $1.7 billion in 2025, then advanced by 0.51% to $1.7 billion in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $1.7 billion in Q1 2026, $1.7 billion in Q4 2025, and -$1.3 billion in Q3 2025.